Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer?
about
Epirubicin: a new entry in the list of fetal cardiotoxic drugs? Intrauterine death of one fetus in a twin pregnancy. Case report and review of literatureCardiac risk in the treatment of breast cancer: assessment and management.Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors.Extraction protocol and mass spectrometry method for quantification of doxorubicin released locally from prodrugs in tumor tissue.Cardiovascular toxicities from systemic breast cancer therapy.Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surfaceDose-dense epirubicin and cyclophosphamide followed by docetaxel as adjuvant chemotherapy in node-positive breast cancerCardiac tolerability of concurrent administration of trastuzumab and anthracycline-based regimen as adjuvant chemotherapy for breast cancer.Identification of genes required for protection from doxorubicin by a genome-wide screen in Saccharomyces cerevisiae.Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes.A nation-wide multicenter 10-year (1999-2008) retrospective study of chemotherapy in Chinese breast cancer patients.
P2860
Q26775577-64121DDD-C2AE-4BF2-BBB5-80D7BA553AE5Q28081385-1EA491EB-C0AE-4338-8969-147A3A31C53BQ33618312-E3CB7C4D-A05D-4FFE-A38C-979EF573AA69Q33701351-BF9302FE-0BC2-4CBF-93A2-4853549D47F8Q33946444-45CE1FD6-34D5-4D92-8665-459ED495B64CQ34630349-ADB1514E-13B9-4226-96B7-82C1AB204EA8Q36356313-BB096B73-F014-4B26-B46A-DAD73AAD9DFDQ37239820-713C80DD-04E9-4FD0-B0AF-D2F8DAB370D2Q37716211-94C440A1-6CDC-4D7A-8FBE-0006D7F8CB70Q40070246-16E4D4F6-0EFB-41BA-BE9B-985D3FDFB1B2Q41483888-57AD1C26-7EC1-4D48-81B9-28ACAB3CE4DEQ46246572-C59D281D-8475-48E0-9201-AD1053D3397E
P2860
Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer?
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Epirubicin versus doxorubicin: ...... he treatment of breast cancer?
@ast
Epirubicin versus doxorubicin: ...... he treatment of breast cancer?
@en
type
label
Epirubicin versus doxorubicin: ...... he treatment of breast cancer?
@ast
Epirubicin versus doxorubicin: ...... he treatment of breast cancer?
@en
prefLabel
Epirubicin versus doxorubicin: ...... he treatment of breast cancer?
@ast
Epirubicin versus doxorubicin: ...... he treatment of breast cancer?
@en
P1476
Epirubicin versus doxorubicin: ...... he treatment of breast cancer?
@en
P2093
Virginia G Kaklamani
William J Gradishar
P304
P407
P478
P577
2003-04-01T00:00:00Z